3DBioFibr is a pioneering startup that operates in the biotechnology sector, specifically in the production of collagen fibers. The company uses a patented dry-spinning technology to replicate the biomechanical and biochemical properties of natural collagen structures. This innovative approach sets them apart in the market, as they are the first to produce collagen fibers on a commercial scale.

The company's primary clients are in the field of tissue engineering, where their collagen fibers are used in various applications. These include additives for 3D bioprinting and hydrogels, and cellular scaffolds for 2D and 3D cell and tissue culture. To put it simply, their products are used to create structures that support the growth of cells and tissues, a crucial component in medical research and treatment development.

3DBioFibr operates on a business-to-business model, selling their products directly to research institutions, healthcare organizations, and other businesses in the biotechnology sector. Their revenue is generated from the sales of their collagen fibers, which are produced using a fully automated manufacturing system. This allows them to scale up production to meet the growing demand in the market.

In summary, 3DBioFibr is a unique player in the biotechnology industry, leveraging their patented technology to produce collagen fibers for tissue engineering applications. Their ability to produce at commercial scales sets them up for significant growth potential in this rapidly advancing field.

Keywords: Biotechnology, Collagen Fibers, Tissue Engineering, 3D Bioprinting, Hydrogels, Cellular Scaffolds, Patented Technology, Automated Manufacturing, Commercial Scale Production, B2B Sales.